ZC3H13 is lowly expressed in hepatocellular carcinoma and may be involved in transcriptional dysregulation or the JAK-STAT pathway to inhibit tumor migration and invasion (Wu et al., 2022[293]). Here, ZC3H13 is linked to neoplasm.